Calcium phosphate nanoparticles show an effective activation of the innate immune response in vitro and in vivo after functionalization with flagellin

Virologica Sinica

Volumn 29, Issue 1, 2014, Pages 33-39

  Kozlova, Diana ^a   Sokolova, Viktoriya ^a   Zhong, Maohua ^b   Zhang, Ejuan ^b   Yang, Jingyi ^b   Li, Wei ^b   Yang, Yi ^b   Buer, Jan ^c   Westendorf, Astrid Maria ^c   Epple, Matthias ^a   Yan, Huimin ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b WUHAN INSTITUTE OF VIROLOGY   (China)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

adjuvants; calcium phosphate; flagellin; immunostimulation; innate immune system; nanoparticle

Indexed keywords

ANIMALS; BACTERIAL VACCINES; CACO-2 CELLS; CALCIUM PHOSPHATES; DRUG CARRIERS; FEMALE; FLAGELLIN; HUMANS; IMMUNITY, INNATE; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; MICE; MICE, INBRED C57BL; NANOPARTICLES; VACCINES, SUBUNIT;

EID: 84895077548     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-014-3379-0     Document Type: Article

References (30)

1. Amicizia D, Domnich A, Panatto D, Lai P L, Cristina M L, Avio U, and Gasparini R. 2013. Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines. Hum Vaccin Immunother, 9: 1163-1171.
2. Blutt S E, Miller A D, Salmon S L, Metzger D W, and Conner M E. 2012. IgA is important for clearance and critical for protection from rotavirus infection. Mucosal Immunol, 5: 712-719.
3. Coffman R L, Sher A, and Seder R A. 2010. Vaccine adjuvants: putting innate immunity to work. Immunity, 4: 492-503.
4. Demento S L, Siefert A L, Bandyopadhyay A, Sharp F A, and Fahmy T M. 2011. Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines. Trends Biotechnol., 29: 294-306.
5. Dorozhkin S V, and Epple M. 2002. Biological and medical significance of calcium phosphates. Angew. Chem. Int. Ed., 41: 3130-3146.
6. Epand R M, and Vogel H J. 1999. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta, 1462: 11-28.
7. Franchi L, Kamada N, Nakamura Y, Burberry A, Kuffa P, Suzuki S, Shaw M H, Kim Y G, and Núñez G. 2012. NLRC4-driven interleukin-1β production discriminates between pathogenic and commensal bacteria and promotes host intestinal defense. Nat. Immunol., 13: 449-456.
8. Frisdal E, Lesnik P, Olivier M, Robillard P, Chapman M J, Huby T, Guerin M, and Le Goff W. 2011. Interleukin-6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinflammatory response. J. Biol. Chem., 35: 30926-30936.
9. Harandi A M, Medaglini D, and Shattock R J. 2010. Vaccine adjuvants: a priority for vaccine research. Vaccine, 28: 2363-2366.
10. Honko A N, and Mizel S B. 2005. Effects of flagellin on innate and adaptive immunity. Immunol Res, 33: 83-101.
11. Klinman D M, Klaschik S, Sato T, and Tross D. 2009. CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases. Adv. Drug Deliv. Rev., 61: 248-255.
12. Knuschke T, Sokolova V, Rotan O, Wadwa M, Tenbusch M, Hansen W, Staeheli P, Epple M, Buer J, and Westendorf A M. 2013. Immunization with biodegradable nanoparticles efficiently induces cellular immunity and protects against influenza virus infection. J. Immunol., 190: 6221-6229.
13. Kozlova D, Chernousova S, Knuschke T, Buer J, Westendorf A M, and Epple M. 2012. Cell targeting by antibody-functionalized calcium phosphate nanoparticles. J. Mater. Chem., 22: 396-404.
14. Krishnamachari Y, and Salem A K. 2009. Innovative strategies for co-delivering antigens and CpG oligonucleotides. Adv. Drug Deliv. Rev., 61: 205-217.
15. Liu F, Yang J, Zhang Y, Zhou D, Chen Y, Gai W, Shi W, Li Q, Tien P, and Yan H. 2010. Recombinant flagellins with partial deletions of the hypervariable domain lose antigenicity but not mucosal adjuvancy. Biochem. Biophys. Res. Commun., 392: 582-587.
16. Mbow M L, De Gregorio E, Valiante N M, and Rappuoli R. 2010. New adjuvants for human vaccines. Curr. Opin. Immunol., 22: 411-416.
17. Miao E A, Andersen-Nissen E, Warren S E, and Aderem A. 2007. TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system. Semin. Immunopathol., 29: 275-288.
18. Mizel S B, and Bates J T. 2010. Flagellin as an adjuvant: cellular mechanisms and potential. J. Immunol., 185: 5677-5682.
19. Neumann S, Kovtun A, Dietzel I D, Epple M, and Heumann R. 2009. The use of size-defined DNA-functionalized calcium phosphate nanoparticles to minimise intracellular calcium disturbance during transfection. Biomaterials, 30: 6794-6802.
20. Shi W, Li Y H, Liu F, Yang J Y, Zhou D H, Chen Y Q, Zhang Y, Yang Y, He B X, Han C, Fan M W, and Yan H M. 2012. Flagellin enhances saliva IgA response and protection of anti-caries DNA vaccine. J. Dent. Res., 91: 249-254.
21. Sokolova V, Knuschke T, Buer J, Westendorf A M, and Epple M. 2011. Quantitative determination of the composition of multi-shell calcium phosphate-oligonucleotide nanoparticles and their application for the activation of dendritic cells. Acta Biomater., 7: 4029-4036.
22. Sokolova V, Knuschke T, Kovtun A, Buer J, Epple M, and Westendorf A M. 2010. The use of calcium phosphate nanoparticles encapsulating toll-like receptor ligands and the antigen hemagglutinin to induce dendritic cell maturation and T cell activation. Biomaterials, 31: 5627-5633.
23. Sokolova V, Kozlova D, Knuschke T, Buer J, Westendorf A M, and Epple M. 2013. Mechanism of the uptake of cationic and anionic calcium phosphate nanoparticles by cells. Acta Biomater., 9: 7527-7535.
24. Sokolova V, Rotan O, Klesing J, Nalbant P, Buer J, Knuschke T, Westendorf A M, and Epple M. 2012. Calcium phosphate nanoparticles as versatile carrier for small and large molecules across cell membranes. J. Nanopart. Res., 14: 910.
25. Sun Y, Shi W, Yang J Y, Zhou D H, Chen Y Q, Zhang Y, Yang Y, He B X, Zhong M H, Li Y M, Cao Y, Xiao Y, Li W, Yu J, Li Y H, Fan M W, and Yan H M. 2012. Flagellin-PAc fusion protein is a high-efficacy anti-caries mucosal vaccine. J. Dent. Res., 91: 941-947.
26. Vijay-Kumar M, Carvalho F A, Aitken J D, Fifadara N H, and Gewirtz A T. 2010. TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin. Eur. J. Immunol., 12: 3528-3534.
27. Wischke C, Zimmermann J, Wessinger B, Schendler A, Borchert H H, Peters J H, Nesselhut T, and Lorenzen D R. 2009. Poly(I:C) coated PLGA microparticles induce dendritic cell maturation. Int. J. Pharm., 1-2: 61-68.
28. Yan H, Lamm M E, Björling E, and Huang Y T. 2002. Multiple functions of immunoglobulin A in mucosal defense against viruses: an in vitro measles virus model. J. Virol., 76: 10972-10979.
29. Yang J, Zhong M, Zhang Y, Zhang E, Sun Y, Cao Y, Li Y, Zhou D, He B, Chen Y, Yang Y, Yu J, and Yan H. 2013. Antigen replacement of domains D2 and D3 in flagellin promotes mucosal IgA production and attenuates flagellin-induced inflammatory response after intranasal immunization. Hum. Vaccin. Immunother., 9: 1084-1092.
30. Yang J, Zhang E, Liu F, Zhang Y, Zhong M, Li Y, Zhou D, Chen Y, Cao Y, Xiao Y, He B, Yang Y, Sun Y, Lu M, and Yan H. 2013. Flagellins of Salmonella Typhi and non-pathogenic Escherichia coli are differentially recognized through NLRC4 pathway in macrophages. J. Innate Immunity: (in press).